High CCT3 expression correlates with poor prognosis and demonstrates strong predictive potential.[83] These findings suggest that CCT3 may serve as a potential biomarker and a promising therapeutic target for cervical cancer. This evidence concerns the gene CCT3 and cervical cancer.